Key Takeaways:
- Rosen Law Firm is investigating Disc Medicine for allegedly misleading investors.
- The probe follows a 22% stock drop on Feb. 13, 2026, after an FDA rejection.
- The firm is preparing a class-action lawsuit to recover investor losses.
Back
Disc Medicine Slumps 22% as Law Firm Probes Claims
Rosen Law Firm said Monday it is investigating potential securities claims against Disc Medicine Inc. after the company’s stock plunged 22% in a single day on negative regulatory news.
"The Rosen Law Firm is preparing a class action seeking recovery of investor losses," the firm stated in a press release issued May 25.
The investigation centers on allegations that Disc Medicine may have issued misleading business information. On Feb. 13, 2026, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company's bitopertin new drug application, citing uncertainties that required more evidence. Disc Medicine's shares fell 22% on the day of the announcement.
The law firm's action seeks to compensate shareholders who purchased securities and suffered losses. Investors who purchased stock may be entitled to compensation without out-of-pocket fees through a contingency arrangement.
The investigation introduces significant legal and financial risk for Disc Medicine, potentially leading to a costly class-action lawsuit. Investors will be watching for the company's formal response to the allegations and any further updates from the FDA on the bitopertin program.
This article is for informational purposes only and does not constitute investment advice.
[1] IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights[2] IRON Investor News: If You Have Suffered Losses in Disc - GlobeNewswire[3] Disc Medicine faces class action after FDA rejects drug application, stock drops 22%. - Pluang[4] INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP - Carroll County Mirror-Democrat[5] INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP - The Killeen Daily Herald
